menu
    • menu

    Company profile for bene Arzneimittel GmbH

    NEW Drugs in Dev: 1
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    bene-Arzneimittel GmbH engages in the production and distribution of pharmaceutical drugs in Germany and internationally. It offers painkillers; products for the treatment of thrombosis prophylaxis, phlebitis, blood fat levels, and urological disorders; pentosan polysulphate sodium products; ben-u-ron, a product for the treatment of mild to moderate pain and/or fever; ib-u-ron to treat slight to moderately strong pains; Thromb...
    bene-Arzneimittel GmbH engages in the production and distribution of pharmaceutical drugs in Germany and internationally. It offers painkillers; products for the treatment of thrombosis prophylaxis, phlebitis, blood fat levels, and urological disorders; pentosan polysulphate sodium products; ben-u-ron, a product for the treatment of mild to moderate pain and/or fever; ib-u-ron to treat slight to moderately strong pains; Thrombocid for the treatment of superficial phlebitis, venous congestion, and leg fatigue; and Tacholiquin for the treatment of lung disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    bene Arzneimittel GmbHGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Herterichstraße 1–3 Munich, 81479
    Telephone
    Telephone
    +49-089-749-870
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bene-arzneimittel.de/en/startseite
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arvo

    Arvo

    Not Confirmed

    envelop Contact Supplier

    Arvo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Medice Arzneimittel Pütter's Abseamed (epoetin alfa) Receives Approval in Europe
    Medice Arzneimittel Pütter's Abseamed (epoetin alfa) Receives Approval in Europe

    04 Oct 2018

    // EMA

    https://www.ema.europa.eu/documents/overview/abseamed-epar-medicine-overview_en.pdf

    EMA
    04 Oct 2018
    Share Share
    Bene-Arzneimittel Co received pentosan polysulfate of orphan medicinal product
    Bene-Arzneimittel Co received pentosan polysulfate of orphan medicinal product

    21 Dec 2015

    // PR NEWS WIRE

    http://www.prnewswire.com/news-releases/firma-bene-arzneimittel-ziskala-pre-pentosan-polysulfat-na-liebu-intersticialnej-cystitidy-status-lieku-na-ojedinele-ochorenia-563137541.html

    PR NEWS WIRE
    21 Dec 2015
    Share Share
    bene-Arzneimittel received orphan drug status for pentosan polysulfate
    bene-Arzneimittel received orphan drug status for pentosan polysulfate

    17 Dec 2015

    // PR NEWS WIRE

    http://www.prnewswire.com/news-releases/bene-arzneimittel-recibe-el-estatus-de-farmaco-huerfano-para-polisulfato-de-pentosan-562970331.html

    PR NEWS WIRE
    17 Dec 2015
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search